Federal Data HubHRSA 340B · JSON

ST LOUIS UNIVERSITY MEDICAL CENTER

CENTER FOR BLEEDING & THROMBOTIC DISORDERS · 340B ID HM10988

Not participatingHemophilia Treatment Center

ST LOUIS UNIVERSITY MEDICAL CENTER is a Hemophilia Treatment Center enrolled in the federal 340B Drug Pricing Program in ST LOUIS, MO. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 9 contract-pharmacy arrangement(s) (0 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (9)

PharmacyLocationBeginTerminatedPharmacy ID
ACCREDO HEALTH GROUP INCWARRENDALE, PA2018-01-012024-07-0123041
ACCREDO HEALTH GROUP INCNASHVILLE, TN2016-10-012024-07-015878
ACCREDO HEALTH GROUP, INCCHESTERFIELD, MO2016-10-012024-07-0161233
ACCREDO HEALTH GROUP, INC.ORLANDO, FL2016-10-012024-07-0139194
ACCREDO HEALTH GROUP, INC.LENEXA, KS2018-01-012024-07-0162883
BIOPARTNERS IN CARE INCLENEXA, KS2015-01-012024-07-012485
CORAM ALTERNATE SITE SERVICES, INC.MENDOTA HEIGHTS, MN2013-07-012024-07-015877
CORAM ALTERNATE SITE SERVICES, INC.SAINT LOUIS, MO2013-07-012024-07-0161479
CORAM ALTERNATE SITE SERVICES, INC.MALVERN, PA2005-04-012024-07-01460

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.